| Title |
Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
|
|---|---|
| Published in |
Clinical and Translational Oncology, October 2018
|
| DOI | 10.1007/s12094-018-1945-x |
| Pubmed ID | |
| Authors |
R. Vera, M. J. Otero, F. Ayala de la Peña, C. González-Pérez, Á. Peñuelas, J. M. Sepúlveda, N. Quer, N. Doménech-Climent, J. A. Virizuela, P. Beorlegui, M. Q. Gorgas |
X Demographics
The data shown below were collected from the profiles of 37 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 18 | 49% |
| Venezuela, Bolivarian Republic of | 1 | 3% |
| El Salvador | 1 | 3% |
| Portugal | 1 | 3% |
| Unknown | 16 | 43% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 26 | 70% |
| Practitioners (doctors, other healthcare professionals) | 11 | 30% |
Mendeley readers
The data shown below were compiled from readership statistics for 67 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 67 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 8 | 12% |
| Student > Master | 7 | 10% |
| Other | 6 | 9% |
| Student > Bachelor | 5 | 7% |
| Student > Doctoral Student | 4 | 6% |
| Other | 14 | 21% |
| Unknown | 23 | 34% |
| Readers by discipline | Count | As % |
|---|---|---|
| Nursing and Health Professions | 13 | 19% |
| Medicine and Dentistry | 8 | 12% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 7% |
| Social Sciences | 4 | 6% |
| Business, Management and Accounting | 2 | 3% |
| Other | 6 | 9% |
| Unknown | 29 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 January 2022.
All research outputs
#1,653,656
of 25,534,033 outputs
Outputs from Clinical and Translational Oncology
#46
of 1,467 outputs
Outputs of similar age
#34,766
of 358,352 outputs
Outputs of similar age from Clinical and Translational Oncology
#5
of 31 outputs
Altmetric has tracked 25,534,033 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,467 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 358,352 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.